University of Hawaii Cancer Center Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • University of Hawaii Cancer Center's estimated annual revenue is currently $27.3M per year.(i)
  • University of Hawaii Cancer Center's estimated revenue per employee is $155,000

Employee Data

  • University of Hawaii Cancer Center has 176 Employees.(i)
  • University of Hawaii Cancer Center grew their employee count by 5% last year.

University of Hawaii Cancer Center's People

NameTitleEmail/Phone
1
Associate Center Director Clinical and Translational ResearchReveal Email/Phone
2
Assistant Professor Cancer EpidemiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8142.9M215429%N/AN/A
Add Company

What Is University of Hawaii Cancer Center?

Imagine life without cancer. It’s our consuming passion at the University of Hawaii Cancer Center where our mission is to be a world leader in eliminating cancer through research, education and improved patient care.

keywords:N/A

N/A

Total Funding

176

Number of Employees

$27.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

University of Hawaii Cancer Center News

2022-04-17 - Global Leaders to Present Breakthroughs in Liquid Biopsy, Early Cancer Detection at S.E.E. Summit

Presentations and panels with biotech, research and oncology experts ... University of Hawaii Cancer Center (Non-Hodgkin's lymphoma cancer...

2022-04-17 - UH researcher identifies peptide active against certain ...

The research team proved that petrichorin A is active against cancers such as ovarian cancer, fibrosarcoma, prostate cancer and T-cell...

2022-03-22 - M?noa: UH attracts $50M in federal biomedical research ...

Burns School of Medicine (JABSOM) and the UH Cancer Center, including: $4,620,000 - Ola HAWAII (JABSOM). The Research Centers in Minority...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.1M17622%N/A
#2
$7.5M17915%N/A
#3
$49.8M179N/AN/A
#4
$15M1795%N/A
#5
$48.1M1809%N/A